The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a novel blood-based RNA gene expression platform for early-stage lung cancer diagnosis.
 
Martin J Keiser
Employment - HepGene; IV BioHoldings; LiquidLung; Mammogen
Leadership - IV BioHoldings; Mammogen
Stock and Other Ownership Interests - IV BioHoldings
 
Elizabeth Cormier-May
Employment - Dragonfly Data Ventures; IV BioHoldings; Mammogen
Leadership - Dragonfly Data Ventures; IV BioHoldings; Mammogen
Stock and Other Ownership Interests - Dragonfly Data Ventures; IV BioHoldings; Mammogen
 
Matthew Alderdice
Employment - Sonrai Analytics
Stock and Other Ownership Interests - Sonrai Analytics
 
Joy N Kavanagh
Employment - Sonrai Analytics
Consulting or Advisory Role - Almac Group (I)
 
Brendon Matthew Stiles
Employment - PPD (I); Xalud Therapeutics (I); Xalud Therapeutics (I)
Leadership - Verrica Pharmaceuticals (I)
Stock and Other Ownership Interests - Pfizer (I); PPD (I); Xalud Therapeutics (I)
Honoraria - AstraZeneca; Bristol Myers Squibb; Genentech; Pfizer
Consulting or Advisory Role - AstraZeneca; Gala Therapeutics; Medtronic; Pfizer
Research Funding - Bristol Myers Squibb Foundation
Patents, Royalties, Other Intellectual Property - A therapeutic antibody targeting ART1, an extracellular mono-ADP ribosyltransferase, for the treatment of cancer. Patent application filed (Inst)
Other Relationship - Lung Cancer Research Foundation; Lungevity